Often Pharmaceuticals Private Limited

Often Pharmaceuticals Private Limited - electrnoics in Dinhata, West Bengal, India. FY 2026 financials & compliance.
CIN U52609WB2018PTC225769 Incorporated 23 April 2018 ROC Kolkata HQ Dinhata, West Bengal, India
Active Private Limited Company electrnoics Startup India
Data last updated
Revenue · FY 2023
₹28,763
▼ 84% YoY
Net loss · FY 2023
₹26,638
Net margin -92.6%
EBITDA · FY 2023
-₹26,638
EBITDA margin -92.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Often Pharmaceuticals Private Limited

Data last updated:

Often Pharmaceuticals Private Limited is a private limited company based in Dinhata, West Bengal, India, recognised as a startup by DPIIT. It operates in the repair services segment of the electronics sector. It was incorporated on 23 April 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U52609WB2018PTC225769. Its GSTIN is 19AACCO6952G1Z6 (West Bengal).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sumita Bera and Dipanjan Nath.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O – Dipanjan Nath Nigamgnagar Near Sharma Electronics, Dinhata, West Bengal, India – 736169.

As per the financials filed for FY 2023, the company reported a revenue of ₹28,763, a decline of 84% compared to the previous year. For the same year it recorded a net loss of ₹26,638 (net margin -92.6%) and EBITDA of -₹26,638 (EBITDA margin -92.6%).

Company details

CIN U52609WB2018PTC225769
Registration Number 225769
Incorporation Date 23 April 2018
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
DPIIT Recognition Recognised Startup

Recognitions & Rankings of Often Pharmaceuticals

Startup India Government of India

Contact details

Often Pharmaceuticals Private Limited's registered office is in Dinhata, West Bengal. Its e-mail address is in the company report.

  • Email
  • Registered Address
    C/O – Dipanjan Nath Nigamgnagar Near Sharma Electronics, Dinhata, West Bengal, India – 736169
  • Industry
    Electrnoics, Repair Services

To see the full contact details of Often Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Often Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Often Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Often Pharmaceuticals Private Limited, buy the company report.

Financials of Often Pharmaceuticals Private Limited

FY 2023 filings available

Often Pharmaceuticals Private Limited reported revenue of ₹28,763 (down 84% YoY) for FY 2023.

Revenue · FY 2023
₹28,763 ▼ 84%
Net loss · FY 2023
₹26,638 margin -92.6%
EBITDA · FY 2023
-₹26,638 margin -92.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 84%
EBITDA CAGR growth
1 year
▼ 222%
3 years · compounded
▼ 58%

Revenue fell 84% in the latest year. EBITDA fell 222% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹26,638
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹26,638
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-92.6%
Net Profit Margin-92.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Often Pharmaceuticals Private Limited, buy the company report.

Board of directors of Often Pharmaceuticals Private Limited

Often Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sumita BeraDirector23 Apr 20188 Years 6 MonthsCurrent
Dipanjan NathDirector23 Apr 20188 Years 6 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Often Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Often Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AACCO6952G1Z6West BengalActive20 Mar 2020

To see the full GST registrations and return filing status of Often Pharmaceuticals Private Limited, buy the company report.

Recent activity

Often Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Dipanjan Nath was appointed as Director on 23 Apr 2018.

AGM
Often Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Often Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kolkata.
Appointed
Dipanjan Nath was appointed as Director.
Appointed
Sumita Bera was appointed as Director.
Incorporation
23 Apr 2018
Often Pharmaceuticals Private Limited was registered on 23 Apr 2018 with Roc Kolkata & aged 8 years 6 months as per MCA records.

Frequently asked questions

Often Pharmaceuticals is an active private limited company based in Dinhata, West Bengal, India. The company works in repair services, within the electronics industry. It was incorporated on 23 April 2018 (8+ years old) and is registered under CIN U52609WB2018PTC225769.

Often Pharmaceuticals has 2 current directors:

The latest financial statements of Often Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Often Pharmaceuticals is 19AACCO6952G1Z6, registered in West Bengal.

The CIN (Corporate Identification Number) of Often Pharmaceuticals is U52609WB2018PTC225769. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Often Pharmaceuticals was incorporated on 23 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kolkata.

Dipanjan Nath was appointed as Director on 23 Apr 2018. Sumita Bera was appointed as Director on 23 Apr 2018.

Yes, Often Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

The registered office of Often Pharmaceuticals is at CO – Dipanjan Nath Nigamgnagar Near Sharma Electronics, Dinhata, West Bengal, India – 736169.

Often Pharmaceuticals operates in the electronics industry, in the repair services segment.